Luteinizing Hormone Releasing Hormone (LHRH) Agonists Market Size

Luteinizing Hormone Releasing Hormone (LHRH) Agonists Market size is anticipated to grow at substantial growth rate during the forecast period i.e., between 2024-2036. 

The LHRH-agonist therapy is widely used for patients with prostate cancer. In males, LHRH agonist manages the growth of prostate cancer by stopping normal hormonal functions in the body. Initially, LHRH agonist stimulates the production of testosterone for a couple of weeks and when the LHRH agonist reaches an elevated level, the human body stops the production of new LHRH. Owing to the consequence, there is no more production of testosterone in the body and low levels of testosterone drops the level of prostate cancer cells in the body. The market is thriving primarily on account of the growing cases of prostate cancer in males.